Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States

Transfusion. 2022 Feb;62(2):483-492. doi: 10.1111/trf.16751. Epub 2021 Dec 3.
No abstract available

Keywords: FDA regulations about COVID-19 convalescent plasma; SARS-CoV-2 serology; convalescent plasma collection.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Antibodies, Viral
  • Blood Donors / legislation & jurisprudence*
  • COVID-19 Serotherapy
  • COVID-19* / therapy
  • Humans
  • Immunization, Passive
  • Pandemics
  • SARS-CoV-2
  • United States / epidemiology

Substances

  • Antibodies, Viral